Singapore markets closed

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.52-0.20 (-1.87%)
At close: 04:00PM EST
10.44 -0.08 (-0.76%)
After hours: 07:54PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts1131212
Avg. Estimate-0.16-0.35-1.11-0.84
Low estimate-0.45-0.49-1.39-1.79
High estimate0.16-0.25-0.810.08
Year ago EPS-0.1-0.4-1.03-1.11
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts1021111
Avg. Estimate77M73.12M268.45M356.11M
Low estimate72.58M71.83M263.86M294M
High estimate91.21M74.4M282.5M409M
Year ago sales47.16M49.92M157.17M268.45M
Sales growth (year/est)63.30%46.50%70.80%32.70%
Earnings history30/12/202130/03/202229/06/202229/09/2022
Est. EPS-0.3-0.37-0.34-0.29
Actual EPS-0.1-0.4-0.32-0.23
Difference0.2-0.030.020.06
Surprise %66.70%-8.10%5.90%20.70%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate-0.16-0.35-1.11-0.84
7 days ago-0.16-0.35-1.11-0.8
30 days ago-0.16-0.35-1.14-0.84
60 days ago-0.23-0.37-1.23-0.78
90 days ago-0.23-0.37-1.23-0.78
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 daysN/AN/A1N/A
Up last 30 daysN/AN/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesBCRXIndustrySector(s)S&P 500
Current qtr.-60.00%N/AN/AN/A
Next qtr.12.50%N/AN/AN/A
Current year-7.80%N/AN/AN/A
Next year24.30%N/AN/AN/A
Next 5 years (per annum)15.20%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A